Oncology Central

Huntington’s ‘super assassin’ gene offers hope for treating cancer

Researchers from Northwestern University (IL, USA) have uncovered the anti-cancer properties of huntingtin, the gene that becomes mutated in Huntington’s disease (HD). The findings were recently published in EMBO Press.

Characteristically, patients with trinucleotide repeat disorders such as HD exhibit severe neurological pathologies but are also known to have reduced cancer susceptibility.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.